248 related articles for article (PubMed ID: 25971329)
1. Recurrence of retinal vein thrombosis with Pycnogenol® or Aspirin® supplementation: a registry study.
Rodriguez P; Belcaro G; Dugall M; Hu S; Luzzi R; Ledda A; Ippolito E; Corsi M; Ricci A; Feragalli B; Cornelli U; Gizzi C; Hosoi M
Panminerva Med; 2015 Sep; 57(3):121-5. PubMed ID: 25971329
[TBL] [Abstract][Full Text] [Related]
2. Recurrent retinal vein thrombosis: prevention with Aspirin, Pycnogenol®, ticlopidine, or sulodexide.
Belcaro G; Dugall M; Bradford HD; Cesarone MR; Feragalli B; Gizzi C; Cotellese R; Hu S; Rodriguez P; Hosoi M
Minerva Cardioangiol; 2019 Apr; 67(2):109-114. PubMed ID: 30964246
[TBL] [Abstract][Full Text] [Related]
3. Pycnogenol® and Centella asiatica in the management of asymptomatic atherosclerosis progression.
Belcaro G; Ippolito E; Dugall M; Hosoi M; Cornelli U; Ledda A; Scoccianti M; Steigerwalt RD; Cesarone MR; Pellegrini L; Luzzi R; Corsi M
Int Angiol; 2015 Apr; 34(2):150-7. PubMed ID: 25519846
[TBL] [Abstract][Full Text] [Related]
4. Prevention of recurrent venous thrombosis and post-thrombotic syndrome.
Belcaro G; Dugall M; Hu S; Feragalli B; Cotellese R; Ledda A; Corsi M; Ricci A; Ippolito E; Errichi BM; Cornelli U; Cesarone MR; Hosoi M
Minerva Cardioangiol; 2018 Jun; 66(3):238-245. PubMed ID: 29795059
[TBL] [Abstract][Full Text] [Related]
5. Delayed progression of atherosclerosis and cardiovascular events in asymptomatic patients with atherosclerotic plaques: 3-year prevention with the supplementation with Pycnogenol®+Centellicum®.
Belcaro G; Cesarone MR; Scipione C; Scipione V; Dugall M; Shu H; Peterzan P; Corsi M; Luzzi R; Hosoi M; Feragalli B; Cotellese R
Minerva Cardioangiol; 2020 Feb; 68(1):15-21. PubMed ID: 31625707
[TBL] [Abstract][Full Text] [Related]
6. Long-haul flights, edema, and thrombotic events: prevention with stockings and Pycnogenol® supplementation (LONFLIT Registry Study).
Belcaro G; Cornelli U; Dugall M; Hosoi M; Cotellese R; Feragalli B
Minerva Cardioangiol; 2018 Apr; 66(2):152-159. PubMed ID: 29512362
[TBL] [Abstract][Full Text] [Related]
7. Improvement in signs and symptoms in psoriasis patients with Pycnogenol® supplementation.
Belcaro G; Luzzi R; Hu S; Cesarone MR; Dugall M; Ippolito E; Corsi M; Caporale S
Panminerva Med; 2014 Mar; 56(1):41-8. PubMed ID: 24637472
[TBL] [Abstract][Full Text] [Related]
8. Prevention of post thrombotic syndrome with Pycnogenol® in a twelve month study.
Errichi BM; Belcaro G; Hosoi M; Cesarone MR; Dugall M; Feragalli B; Bavera P; Hosoi M; Zulli C; Corsi M; Ledda A; Luzzi R; Ricci A
Panminerva Med; 2011 Sep; 53(3 Suppl 1):21-7. PubMed ID: 22108473
[TBL] [Abstract][Full Text] [Related]
9. Central cardiovascular calcifications: supplementation with Pycnogenol® and Centellicum®: variations over 12 months.
Hu S; Belcaro G; Cesarone MR; Feragalli B; Cotellese R; Dugall M; Scipione C; Scipione V; Maione C
Minerva Cardioangiol; 2020 Feb; 68(1):22-26. PubMed ID: 31633315
[TBL] [Abstract][Full Text] [Related]
10. Improvement in symptoms and cochlear flow with pycnogenol in patients with Meniere's disease and tinnitus.
Luzzi R; Belcaro G; Hu S; Dugall M; Hosoi M; Cacchio M; Ippolito E; Corsi M
Minerva Med; 2014 Jun; 105(3):245-54. PubMed ID: 24988090
[TBL] [Abstract][Full Text] [Related]
11. Pycnogenol may alleviate adverse effects in oncologic treatment.
Belcaro G; Cesarone MR; Genovesi D; Ledda A; Vinciguerra G; Ricci A; Pellegrini L; Gizzi G; Ippolito E; Dugall M; Cacchio M; Di Renzo A; Stuard S
Panminerva Med; 2008 Sep; 50(3):227-34. PubMed ID: 18927527
[TBL] [Abstract][Full Text] [Related]
12. Improvement of common cold with Pycnogenol®: a Winter registry study.
Belcaro G; Shu H; Luzzi R; Dugall M; Ippolito E; Cesarone MR; Corsi M; Feragalli B
Panminerva Med; 2014; 56(4):301-8. PubMed ID: 25424463
[TBL] [Abstract][Full Text] [Related]
13. Supplementary management with Pycnogenol® in patients with lupus vasculitis in remission phases: a pilot, concept registry study.
Cesarone MR; Belcaro G; Corsi M; Scipione C; Scipione V; Hu S; Hosoi M; Ledda A; Feragalli B; Cotellese R
Minerva Cardioangiol; 2020 Apr; 68(2):146-152. PubMed ID: 32429631
[TBL] [Abstract][Full Text] [Related]
14. Pycnogenol® supplementation to relieve symptoms after hemorrhoidectomy.
Belcaro G; Cotellese R; Corsi M; Cesarone MR; Scipione C; Scipione V; Cornelli U; Ippolito E; Dugall M; Hosoi M; Feragalli B
Minerva Surg; 2024 Jun; 79(3):309-314. PubMed ID: 38847768
[TBL] [Abstract][Full Text] [Related]
15. Idiopathic myalgic pain (fibromyalgia): supportive management and prevention with Pycnogenol®.
Belcaro G; Hu S; Cesarone MR; Dugall M; Scipione C; Scipione V; Hosoi M; Ledda A; Cornelli U; Feragalli B; Cotellese R
Panminerva Med; 2021 Mar; 63(1):46-50. PubMed ID: 33541059
[TBL] [Abstract][Full Text] [Related]
16. Effects of Pycnogenol® on endothelial dysfunction in borderline hypertensive, hyperlipidemic, and hyperglycemic individuals: the borderline study.
Hu S; Belcaro G; Cornelli U; Luzzi R; Cesarone M; Dugall M; Feragalli B; Errichi B; Ippolito E; Grossi M; Hosoi M; Gizzi G; Trignani M
Int Angiol; 2015 Feb; 34(1):43-52. PubMed ID: 25391252
[TBL] [Abstract][Full Text] [Related]
17. Pycnogenol® in postpartum symptomatic hemorrhoids.
Belcaro G; Gizzi G; Pellegrini L; Dugall M; Luzzi R; Corsi M; Ippolito E; Ricci A; Cesarone MR; Ledda A; Bottari A; Errichi BM
Minerva Ginecol; 2014 Feb; 66(1):77-84. PubMed ID: 24569406
[TBL] [Abstract][Full Text] [Related]
18. Is aspirin still the drug of choice for management of patients with peripheral arterial disease?
Poredos P; Jezovnik MK
Vasa; 2013 Mar; 42(2):88-95. PubMed ID: 23485835
[TBL] [Abstract][Full Text] [Related]
19. Pycnogenol® and Centella asiatica to prevent asymptomatic atherosclerosis progression in clinical events.
Belcaro G; Dugall M; Ippolito E; Hosoi M; Cornelli U; Ledda A; Scoccianti M; Cesarone MR; Pellegrini L; Luzzi R; Corsi M; Feragalli B
Minerva Cardioangiol; 2017 Feb; 65(1):24-31. PubMed ID: 26505327
[TBL] [Abstract][Full Text] [Related]
20. The COFU3 Study. Improvement in cognitive function, attention, mental performance with Pycnogenol® in healthy subjects (55-70) with high oxidative stress.
Belcaro G; Dugall M; Ippolito E; Hu S; Saggino A; Feragalli B
J Neurosurg Sci; 2015 Dec; 59(4):437-46. PubMed ID: 26635191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
